Le Lézard
Classified in: Science and technology, Business
Subjects: ACC, SHM

CELLCOM ISRAEL LTD. (the "Company") Announcement of A Special General Meeting of The Shareholders of The Company (the "Meeting")


NETANYA, Israel, July 13, 2023 /PRNewswire/ -- Cellcom Israel Ltd. (TASE: CEL) (the "Company(" announces that the Meeting will convene on Monday, August 21, 2023, at 15:00 p.m. (Israel time), at the offices of the Company, 10 Ha'gavish Street, Netanya, Israel. An adjourned Meeting, if required, will be held on Monday, August 28, 2023, at the same time and at the same place. The record date for the Meeting is Thursday, July 20, 2023.

The Agenda of the Meeting

  1.  Approve the Compensation Policy.
  2.  Approve granting indemnification and exemption letters to office holders.

Voting Instructions

The summon statement and the voting card published by the Company on July 13, 2023 regarding the convening of the Meeting (the "Meeting's Documents") may be viewed on the Magna distribution website at: www.magna.isa.gov.il and on the Tel-Aviv Stock Exchange Ltd. website at: www.maya.tase.co.il.

Section 4.11 of the summon statement contains voting instructions for shareholders whose shares are not held via a member of the TASE Clearinghouse (for trading on the Tel Aviv Stock Exchange) but instead via a member of the Depositary Trust Company (DTC) or Shareholders who are registered directly with the Company's U.S. transfer agent, American Stock Transfer & Trust Company.

An Unregistered Shareholder is entitled to vote through the Electronic Voting System. Voting through an Electronic voting card shall be possible until six (6) hours before the assembly time of the General Meeting. In addition, an Unregistered Shareholder shall be entitled to deliver the certificate of ownership through the Electronic Voting System

A shareholder is also entitled to vote at the General Meeting through a voting card. Voting in writing shall be made by way of the second part of the voting card, which is attached to the Report.

The voting card and documents that must be attached thereto as set forth in the voting card, must be delivered to the Company's offices (including by registered mail) including the certificate of ownership (and with respect to a registered shareholder - including a photocopy of an identity card, passport, or certificate of incorporation, as applicable) until four (4) hours before the assembly time of the General Meeting. For this purpose, "time of delivery" is the time on which the voting card and the documents attached thereto arrived at the Company's offices.

Company Contact

Gadi Attias
Chief Financial Officer
[email protected]
Tel: +972-52-998-4774

Investor Relations Contact

Elad Levy
Investor Relations Manager
[email protected]
Tel: +972-52-998-4774

 

 

 

SOURCE Cellcom Israel Ltd.


These press releases may also interest you

at 23:00
Flourish Ventures, an early-stage venture capital firm with purpose, today announced the appointment of Ravi Kaushik as Executive Director, Head of Asia Investments. Ravi will lead the global firm's fintech investments and portfolio management in...

at 22:17
ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of information and communication technology solutions, today announced that it was honored with 2023 Climate...

at 22:04
During the second phase of the 135th China Import and Export Fair ("Canton Fair" or "the Fair"), a significant memorandum of cooperation was signed between the Fair and the Guangzhou Branch of the National Archives of Publications and Culture,...

at 21:57
Hikvision has released its full-year 2023 financial results, reporting a total revenue of RMB 89.34 billion, up 7.42% year-over-year. Net profit attributable to shareholders of the company was RMB 14.11 billion, achieving a year-over-year (YoY)...

at 21:05
DTEN, a leading provider of video conferencing solutions, is proud to announce that their flagship All-in-One solution, the DTEN D7X series, is now available to purchase in South Korea after it has successfully passed the rigorous certification...

at 20:15
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer's disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration (FDA)...



News published on and distributed by: